Your browser doesn't support javascript.
loading
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease.
Cohen, Camille; Royer, Bruno; Javaugue, Vincent; Szalat, Raphael; El Karoui, Khalil; Caulier, Alexis; Knebelmann, Bertrand; Jaccard, Arnaud; Chevret, Sylvie; Touchard, Guy; Fermand, Jean-Paul; Arnulf, Bertrand; Bridoux, Frank.
Afiliación
  • Cohen C; Department of Nephrology, Necker Hospital, Paris, France.
  • Royer B; Department of Hematology, CHU Amiens, Amiens, France.
  • Javaugue V; Department of Nephrology, CHU Poitiers, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Poitiers, France.
  • Szalat R; Department of Immunology and Hematology, Saint Louis Hospital, Paris, France.
  • El Karoui K; Department of Nephrology, Necker Hospital, Paris, France.
  • Caulier A; Department of Hematology, CHU Amiens, Amiens, France.
  • Knebelmann B; Department of Nephrology, Necker Hospital, Paris, France.
  • Jaccard A; Department of Hematology, CHU Limoges, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Limoges, France.
  • Chevret S; Department of Biostatistics and Informatics, Saint Louis Hospital, Paris, France.
  • Touchard G; Department of Nephrology, CHU Poitiers, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Poitiers, France.
  • Fermand JP; Department of Immunology and Hematology, Saint Louis Hospital, Paris, France.
  • Arnulf B; Department of Immunology and Hematology, Saint Louis Hospital, Paris, France.
  • Bridoux F; Department of Nephrology, CHU Poitiers, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Poitiers, France.
Kidney Int ; 88(5): 1135-43, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26176826
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Macroglobulinemia de Waldenström / Bortezomib / Enfermedades Renales / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2015 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Macroglobulinemia de Waldenström / Bortezomib / Enfermedades Renales / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2015 Tipo del documento: Article País de afiliación: Francia